Skip to main content

Table 3 Comparison of choroidal parameters in IVB-treated and laser-treated ROP patients

From: Choroidal measurements in decision making for retinopathy of prematurity: a decision tree analysis

Variable

Treatment

Diff.

95% CI (confidence interval)

P value

IVB

Laser

Lower

Upper

Area

 Mean ± SD

398 ± 84

444 ± 117

− 54.6

− 128.0

18.7

0.142

 Median (range)

370 (310 to 520)

440 (210 to 810)

    

Stromal area

 Mean ± SD

265 ± 61

321 ± 71

− 52.7

− 98.1

− 7.3

0.024

 Median (range)

269 (187 to 394)

316 (182 to 528)

    

Luminal area

 Mean ± SD

133 ± 54

123 ± 79

− 2.8

− 52.5

46.9

0.910

 Median (range)

126 (45 to 202)

97 (26 to 340)

    

Choroidal vascular index (CVI)

 Mean ± SD

67 ± 12

74 ± 11

− 4.1

− 11.4

3.1

0.259

 Median (range)

65 (53 to 86)

75 (48 to 92)

    

Choroidal stromal index (CSI)

 Mean ± SD

32 ± 12

26 ± 11

4.1

− 3.1

11.4

0.259

 Median (range)

35 (14 to 47)

25 (8 to 52)

    

Foveal choroidal thickness (FCT)

 Mean ± SD

274 ± 63

309 ± 86

− 38.8

− 85.5

7.8

0.1

 Median (range)

248 (200 to 420)

300 (130 to 580)

    

Temporal choroidal thickness 500 (TCT 500)

 Mean ± SD

234 ± 43

268 ± 58

− 31.2

− 64.9

2.6

0.070

 Median (range)

(194 to 322)

(128 to 433)

    

Temporal choroidal thickness 250 (TCT 250)

 Mean ± SD

245 ± 51

276 ± 62

− 30.2

− 66.2

5.9

0.100

 Median (range)

227 (200 to 370)

280 (135 to 461)

    

Sub-foveal choroidal thickness (SFCT)

 Mean ± SD

260 ± 57

288 ± 67

− 27.5

− 67.1

12.1

0.171

 Median (range)

242 (200 to 410)

298 (132 to 462)

    

Nasal choroidal thickness 250 (NCT250)

 Mean ± SD

258 ± 72

289 ± 68

− 34.4

− 75.1

6.3

0.096

 Median (range)

230 (197 to 433)

295 (108 to 435)

    

Nasal choroidal thickness 500 (NCT500)

 Mean ± SD

258 ± 91

286 ± 62

− 31.8

− 71.1

7.5

0.111

 Median (range)

230 (168 to 487)

290 (152 to 423)

    
  1. SD standard deviation, IVB intravitreal bevacizumab